# Safety and Efficacy of Exenatide as Monotherapy

> **NCT00381342** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 233 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** exenatide
- **DRUG:** exenatide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00381342
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2015-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381342, "Safety and Efficacy of Exenatide as Monotherapy". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00381342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*